RxDoctor Payments Data

Tamara Olt, MD

Gynecology · Peoria, ILNPI 1104870708

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $222 and has fallen 63.5% since, to $81 in 2024. That places this record below the midpoint for gynecology clinicians in IL, where the typical reported total is $520.

$609in general payments, 2019–2025

Across 36 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$124
  • Orexo US, Inc.$104
  • Astellas Pharma US Inc$90
  • Lupin Inc.$57
  • Daiichi Sankyo Inc.$51
  • Avion Pharmaceuticals$33
  • plus $149 from 9 others

What the payments were for

  • Food & beverage$609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$609 in reported general payments places this provider in the 50th percentile of 68 gynecology providers in Illinois.

See all gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$23,745
Medicare patients
148
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol94$7,492
YuvafemEstradiol23$3,227
Clobetasol Propionate33$810
Buprenorphine Hcl13$696
Medroxyprogesterone Acetate21$584
SynthroidLevothyroxine Sodium11$488
ProgesteroneProgesterone, Micronized18$406
Venlafaxine Hcl ErVenlafaxine Hcl13$312
ValacyclovirValacyclovir Hcl17$293
Fluconazole30$201
Metformin Hcl ErMetformin Hcl11$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$124$48811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 68 gynecology providers in Illinois.

Other gynecology in Peoria

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →